1ST Biotherapeutics, Inc.
PrivateLast Round
Strategic
Sep 17, 2026
Total Funding Raised
$98.23M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
1ST Biotherapeutics, Inc. operates in Healthcare & Life Sciences and is based in Yongin-si. Its latest recorded funding round was a Strategic round in September 2026.
1ST Biotherapeutics, Inc. is a biotechnology company that develops a pipeline of small molecule therapeutics for neurodegenerative diseases, immuno-oncology, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1ST Biotherapeutics, Inc. Comparables
Compare 1ST Biotherapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BeyondBio | 83% | |
| Neuron23 | 83% | |
| Origami Therapeutics | 76% |
For institutional investors. Book with your work email.
1ST Biotherapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 17, 2026 | ||||
| Series D | Jan 26, 2026 | ||||
| Series C Extension | Jul 14, 2023 | ||||
| VC Round | Jul 30, 2020 | ||||
| Series B | Apr 17, 2018 | ||||
Series A | Nov 30, 2016 |
For institutional investors. Book with your work email.
1ST Biotherapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Woori Investment & Securities | Series D |
| InterVest | Series B |
| LigaChem Biosciences | Series D |
| BNH INVESTMENT | Series B |
| CKD Venture Capital | Series D |
| Shinhan Venture Investment | VC Round |
| Smilegate Investment | Series C Extension, VC Round, Series A, Series B, Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2026
Raised $2.2M with SK Biopharmaceuticals Co., Ltd. as an investor.
- Jan 26, 2026
$22M round led by Groom Investment and Smilegate Investment.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 17, 2026
1st Biotherapeutics, Inc. received financing of $2.2M in strategic equity investment on Sep 17th '26.
For institutional investors. Book with your work email.
1ST Biotherapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 1ST Biotherapeutics, Inc.'s valuation, stock price, and market status.
Is 1ST Biotherapeutics, Inc. a public or private company?
1ST Biotherapeutics, Inc. is a private company.
What is the current stock price of 1ST Biotherapeutics, Inc.?
1ST Biotherapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks 1ST Biotherapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 1ST Biotherapeutics, Inc. worth (valuation)?
Valuation information for 1ST Biotherapeutics, Inc. is not publicly available.
Can I buy 1ST Biotherapeutics, Inc. stock?
1ST Biotherapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 1ST Biotherapeutics, Inc.'s last funding round?
1ST Biotherapeutics, Inc.'s most recent funding round was Strategic on September 17, 2026.
Who are the main investors in 1ST Biotherapeutics, Inc.?
Key investors in 1ST Biotherapeutics, Inc. include Smilegate Investment, Groom Investment.
Will 1ST Biotherapeutics, Inc. IPO soon?
No public IPO plans have been announced for 1ST Biotherapeutics, Inc..
How can I track 1ST Biotherapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in 1ST Biotherapeutics, Inc.'s shares on secondary markets.